Showing results (41-50 of 344) with videos related to
Sort By:
Pageof 35
Journal of Market Access & Health Policy|July 26, 2017
Should new health technology be available only for patients able and willing to pay?Piet Calcoen, Albert Boer, Wynand P M M van de VenJournal of Market Access & Health Policy|July 26, 2017
Use and cost comparison of clobazam to other antiepileptic drugs for treatment of Lennox-Gastaut syndromeClément François, John M Stern, Augustina Ogbonnaya, et al.Journal of Market Access & Health Policy|July 26, 2017
Direct cost analysis of the second year post-allogeneic hematopoietic stem cell transplantation in the Bone Marrow Transplant Centre of TunisiaMyriam Razgallah Khrouf, Leila Achour, Asma Thabti, et al.Journal of Market Access & Health Policy|July 26, 2017
Patient access to reimbursed biological disease-modifying antirheumatic drugs in the European regionZoltán Kaló, Zoltán Vokó, Andrew Östör, et al.Journal of Market Access & Health Policy|August 15, 2017
Policy implementation for methicillin-resistant Staphylococcus aureus in seven European countries: a comparative analysis from 1999 to 2015Takuya Kinoshita, Hironobu Tokumasu, Shiro Tanaka, et al.Journal of Market Access & Health Policy|August 26, 2017
A comparative review of Haute Autorité de Santé and National Institute for Health and Care Excellence health technology assessments of Ikervis® to treat severe keratitis in adult patients with dry eye disease which has not improved despite treatment with tear substitutesYasmina Iffet ErogluJournal of Market Access & Health Policy|July 8, 2016
Validation of disease states in schizophrenia: comparison of cluster analysis between US and European populationsKatia Thokagevistk, Aurélie Millier, Leslie Lenert, et al.Journal of Market Access & Health Policy|May 27, 2016
Economic impact of new active substance status on EU payers' budgets: example of dimethyl fumarate (Tecfidera(®)) for multiple sclerosisMondher Toumi, Guy JadotJournal of Market Access & Health Policy|May 23, 2018
Towards a more comprehensive approach for a total economic assessment of vaccines?: 1. The building blocks for a health economic assessment of vaccinationBaudouin Standaert, Rino RappuoliJournal of Market Access & Health Policy|May 15, 2023
Quantitative revenue estimates and qualitative assessments of innovative fundraising sources for treating rare diseases in ColombiaSurrey M Walton, Wilson Mayorga, Angela Rodríguez Narváez, et al.Pageof 35